Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis

Introduction: Moderate hypofractionated (HF) radiotherapy is becoming the new standard in radiotherapy for prostate cancer patients. It is established as safe, but it might be associated with increased acute toxicity levels. We conducted a systematic review on moderate HF to establish acute toxicity...

Full description

Bibliographic Details

Published in:	Clinical and Translational Radiation Oncology
Main Authors:	F. Sinzabakira, V. Brand, W.D. Heemsbergen, L. Incrocci
Format:	Article
Language:	English
Published:	Elsevier 2023-05-01
Subjects:	Prostate cancer Radiotherapy Hypofractionation Toxicity
Online Access:	http://www.sciencedirect.com/science/article/pii/S240563082300037X